Frontline Triplet With Bortezomib: New Standard in Myeloma? Frontline Triplet With Bortezomib: New Standard in Myeloma?

Bortezomib added to lenalidomide plus dexamethasone significantly increased both progression-free and overall survival in multiple myeloma.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news